Runx1 Familial Platelet Disorder

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-12-26
Clinical Trial Update: Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder [Phase 1]
Phase 1 clinical trial evaluating the safety and feasibility of autologous CD34+ hematopoietic stem cell mobilization and apheresis in parti…